CVS Crosses Above Average Analyst Target
February 14, 2025 at 07:06 AM EST
In recent trading, shares of CVS Health Corporation (CVS) have crossed above the average analyst 12-month target price of $64.64, changing hands for $66.37/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..